Huge variations between countries in time for reimbursement decisions on new cancer drugs [ESMO 2018 Press Release]
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, Switzerland, European Union and Organisations, France, Germany, United Kingdom
Keywords: Business, Medical & pharmaceutical, Health, Medical, Policy
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.